Acapatamab (AMG-160) is a monoclonal antibody designed to target both CD3E and FOLH1. This dual-targeting biologic is engineered for the potential treatment of various cancers, leveraging its ability to bind to CD3E on T cells and FOLH1 on tumor cells, thereby facilitating a targeted immune response against cancerous tissues. Acapatamab is primarily used in research focused on cancer immunotherapy and the study of bispecific antibody mechanisms.
Acapatamab (AMG-160) is a monoclonal antibody designed to target both CD3E and FOLH1. This dual-targeting biologic is engineered for the potential treatment of various cancers, leveraging its ability to bind to CD3E on T cells and FOLH1 on tumor cells, thereby facilitating a targeted immune response against cancerous tissues. Acapatamab is primarily used in research focused on cancer immunotherapy and the study of bispecific antibody mechanisms.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
